Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of High-dose Intravenous Selenium (Selenase®) on the Systemic Inflammatory Response Syndrome and Related Organ Dysfunction

NCT01141556 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT01141556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01141556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of High-dose Intravenous Selenium (Selenase®) on the Systemic Inflammatory Response Syndrome and Related Organ Dysfunction
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2010
Completion date
September 30, 2012
Enrollment
410 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

heart; surgery, heart, functional disturbance as result, self efficacy